260 related articles for article (PubMed ID: 26346076)
1. Omalizumab for chronic spontaneous urticaria: a boon for sufferers, but there are unanswered questions.
Greaves MW
Br J Dermatol; 2015 Aug; 173(2):321. PubMed ID: 26346076
[No Abstract] [Full Text] [Related]
2. Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice.
Bongiorno MR; Crimi N; Corrao S; Allotta A; Arena A; Brusca I; Heffler E; Malara G; Milioto M; Pistone G; Porto M; Raia E; Valenti G
Ann Allergy Asthma Immunol; 2016 Dec; 117(6):703-707. PubMed ID: 27720581
[No Abstract] [Full Text] [Related]
3. Home self-administration of omalizumab for chronic spontaneous urticaria.
Denman S; Ford K; Toolan J; Mistry A; Corps C; Wood P; Savic S
Br J Dermatol; 2016 Dec; 175(6):1405-1407. PubMed ID: 27639259
[No Abstract] [Full Text] [Related]
4. Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria.
Giménez-Arnau AM; Toubi E; Marsland AM; Maurer M
J Eur Acad Dermatol Venereol; 2016 Jul; 30 Suppl 5():25-32. PubMed ID: 27286500
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab in An 8-Year-Old Boy With Diabetes Mellitus and Refractory Chronic Spontaneous Urticaria.
Jesenak M; Ciljakova M; Janickova M; Banovcin P
J Investig Allergol Clin Immunol; 2019 Apr; 29(2):144-146. PubMed ID: 31017115
[No Abstract] [Full Text] [Related]
6. Chronic spontaneous urticaria in an 8-year-old girl treated with omalizumab.
Ossorio-García L; Jiménez-Gallo D; Albarrán-Planelles C; Arjona-Aguilera C; Linares-Barrios M
Clin Exp Dermatol; 2016 Dec; 41(8):929-930. PubMed ID: 27761937
[No Abstract] [Full Text] [Related]
7. Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria.
Koski R; Kennedy KK
Ann Allergy Asthma Immunol; 2017 Nov; 119(5):397-401. PubMed ID: 29150066
[No Abstract] [Full Text] [Related]
8. Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience.
Ensina LF; de Lacerda AE; Machado LM; Camelo-Nunes I; Solé D
Ann Allergy Asthma Immunol; 2015 Dec; 115(6):536. PubMed ID: 26653279
[No Abstract] [Full Text] [Related]
9. Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.
Skander D; Allenova A; Maurer M; Kolkhir P
Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):91-93. PubMed ID: 32496030
[No Abstract] [Full Text] [Related]
10. Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.
Saini SS; Omachi TA; Trzaskoma B; Hulter HN; Rosén K; Sterba PM; Courneya JP; Lackey A; Chen H
J Invest Dermatol; 2017 Apr; 137(4):958-961. PubMed ID: 27939380
[No Abstract] [Full Text] [Related]
11. Omalizumab for the treatment of chronic spontaneous urticaria in daily clinical practice in South Spain.
Ruiz-Villaverde R; Pereyra-Rodriguez JJ; Hernández-Montoya C; Galán-Gutierrez M; Alcantara-Luna S; Lara-Jimenez MA
Dermatol Ther; 2018 Sep; 31(5):e12669. PubMed ID: 30063807
[No Abstract] [Full Text] [Related]
12. Chronic Idiopathic Urticaria.
Wu EY; Saini SS
J Allergy Clin Immunol Pract; 2015; 3(6):1003-4; quiz 105. PubMed ID: 26553623
[No Abstract] [Full Text] [Related]
13. A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria.
Harris JM; Cabanski CR; Scheerens H; Samineni D; Bradley MS; Cochran C; Staubach P; Metz M; Sussman G; Maurer M
J Allergy Clin Immunol; 2016 Dec; 138(6):1730-1732. PubMed ID: 27567329
[No Abstract] [Full Text] [Related]
14. Efficacy of omalizumab 150 mg/month as a maintenance dose in patients with severe chronic spontaneous urticaria showing a prompt and complete response to the drug.
Asero R
Allergy; 2018 Nov; 73(11):2242-2244. PubMed ID: 29989179
[No Abstract] [Full Text] [Related]
15. Wells syndrome and chronic spontaneous urticaria: report of four cases successfully treated with omalizumab.
Ogueta I; Spertino J; Deza G; Alcantara Luna S; Zaragoza Ninet V; Pujol RM; Giménez-Arnau AM
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):e388-e391. PubMed ID: 31106467
[No Abstract] [Full Text] [Related]
16. Omalizumab-induced triphasic anaphylaxis in a patient with chronic spontaneous urticaria.
Gönül M; Özenergün Bittacı A; Ergin C
J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e135-e136. PubMed ID: 26446412
[No Abstract] [Full Text] [Related]
17. Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab.
Weller K; Ohanyan T; Hawro T; Ellrich A; Sussman G; Koplowitz J; Gimenez-Arnau AM; Peveling-Oberhag A; Staubach P; Metz M; Maurer M
Allergy; 2018 Dec; 73(12):2406-2408. PubMed ID: 30076605
[No Abstract] [Full Text] [Related]
18. Efficacy and Safety of Omalizumab in a Patient With Chronic Spontaneous Urticaria and Active Hepatitis B Virus Infection.
Chicharro P; Rodríguez-Jiménez P; de Argila D
Actas Dermosifiliogr; 2017 May; 108(4):383-384. PubMed ID: 27914623
[No Abstract] [Full Text] [Related]
19. Serial D-dimer plasma levels in a patient with chronic spontaneous urticaria developing resistance to omalizumab.
Asero R
Clin Exp Dermatol; 2017 Aug; 42(6):667-669. PubMed ID: 28691309
[TBL] [Abstract][Full Text] [Related]
20. Use of omalizumab in the treatment of chronic urticaria.
Cordeiro Moreira AS; Rosmaninho Lopes de Soares E Silva MI; Pereira Guilherme MA; da Silva Ferreira JA; Fonseca Moreira da Silva JP
Eur Ann Allergy Clin Immunol; 2016 Nov; 48(6):242-246. PubMed ID: 27852430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
